PureHealth Achieves AED 1.55 Billion Profit In First Nine Months Of 2025 Driven By Strong Healthcare Performance

PureHealth Holding PJSC, the Middle East's largest healthcare group, announced impressive financial outcomes for the nine months ending 30th September 2025. The group achieved AED20.1 billion in revenue, marking a 6% increase from the previous year. EBITDA grew by 11% to AED3.5 billion, while net profit rose by 8% to AED1.55 billion.

The group's expansion into new markets and investment in digital and clinical capabilities are key factors for sustainable growth, according to Kamal Al Maazmi, Chairman of PureHealth. He stated that these results highlight the strength of their integrated model and long-term vision.

In a significant move towards global expansion, PureHealth completed its acquisition of Hellenic Healthcare Group (HHG) during the third quarter. This acquisition enhances their clinical, operational, and research capabilities internationally. The deal involved an €800 million (AED3.1 billion) investment, adding 11 hospitals and 23 diagnostic centres in Greece and Cyprus.

The Care vertical saw a revenue increase of 3%, reaching AED14.4 billion. Outpatient volumes rose by 12%, while inpatient volumes increased by 9% across UAE and UK networks. Circle Health in the UK reported strong performance in orthopaedics, cardiology, oncology, and general medicine.

The Cover vertical experienced a 13% rise in revenue to AED5.7 billion due to a 7% growth in memberships reaching 3.3 million and a similar increase in gross written premiums to AED5.9 billion. Daman introduced an AI-powered document intelligence platform that processes over 60 million documents annually.

Shaista Asif, Group CEO, highlighted the company's progress in expanding its network and global reach. "Growth was driven by solid execution across both Care and Cover segments," she said, noting increased patient engagement and higher diagnostic activity as key contributors.

Future Prospects and Strategic Goals

Looking forward, PureHealth plans to expand its global presence further while deepening clinical specialisation and accelerating AI-driven healthcare solutions. With over half of its assets now located outside the UAE, the group is well-positioned for sustainable growth.

Rafed has been appointed as the exclusive distributor for Abu Dhabi’s Unified Procurement Programme and logistics partner for the regional vaccine distribution hub. This strategic role enhances their logistical capabilities within the region.

"The acquisition of Hellenic Healthcare Group marks a step-change in our global capabilities," Shaista Asif added, emphasising ongoing investments in digital infrastructure for more efficient care delivery.

The group's strategic initiatives aim to deliver long-term value for patients, partners, and shareholders while maintaining a focus on innovation through AI-driven solutions.

With inputs from WAM